Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Discovery of counterfeit hepatitis C drug is another example of why importation is bad for patients

By Nicole Longo  |    February 13, 2017
The manufacturing and trafficking of counterfeit drugs is not just a U.S. concern but a growing threat globally. Governments around the world are working together to try to prevent these fake...   Read More

Stopping opioid abuse

By Anne McDonald Pritchett, PhD  |    May 6, 2016
According to the U.S. Centers for Disease Control and Prevention (CDC), more than 14,000 people died from overdoses involving opioids in 2014—a four-fold increase since 2009. The agency has...   Read More

Phased-in approach offers best hope for FDA’s proposed quality metrics program

By Camille Jackson  |    April 7, 2016
In July 2015, the U.S. Food and Drug Administration (FDA) issued draft guidance for industry requiring manufacturers to provide certain manufacturing data on an annual basis. The FDA’s Center for...   Read More

Research doesn’t end on a medicine’s approval

By Andrew Powaleny  |    March 16, 2016
Research is a critical part of the development of new medicines, but it doesn’t stop once the medicine is approved by the U.S. Food and Drug Administration (FDA).  In fact, that’s when...   Read More

MyOldMeds campaign launches in Massachusetts

By Priscilla VanderVeer  |    February 25, 2016
Every day in Massachusetts, four people die from an opioid overdose. It is one of the most difficult public health challenges facing the Commonwealth, and the country. Prescription drug abuse...   Read More

Improving PDMPs: Strengthening state tools to prevent prescription drug abuse

By Guest Contributor  |    December 2, 2015
The problem of prescription drug abuse is complex and multi-faceted, and addressing the issue requires a multi-pronged, sustained approach involving a broad range of stakeholders. PhRMA and its...   Read More

Upcoming Forum on Improving Critical Tools for Preventing Prescription Drug Abuse

By Anne McDonald Pritchett, PhD  |    June 1, 2015
On June 2, the Network for Excellence in Health Innovation (NEHI) will bring experts from across the country to Boston to discuss a critical public health challenge—the abuse of prescription...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates